Literature DB >> 3013784

Studies in healthy human T-cell-leukemia lymphoma virus (HTLV-I) carriers from the Caribbean.

E Matutes, A G Dalgleish, R A Weiss, A P Joseph, D Catovsky.   

Abstract

Six healthy relatives of 3 adult T-cell leukemia lymphoma (ATLL) patients and 6 members of a Caribbean family immigrant to the UK have been investigated for the presence of HTLV-I and expression of interleukin 2 (IL-2) receptors. Serum antibodies to HTLV-I were detected in all but 4 samples. Four to 10% of circulating cells from 3/4 seropositive donors studied displayed IL-2 receptors (anti-Tac+) and were shown to be convoluted lymphocytes by light microscopy morphology and immunoelectronmicroscopy. After 5 to 28 days in culture, cells from 4 seropositive donors reacted with monoclonal antibodies (MAbs) against the HTLV-I core proteins, p19 and p24, and released retrovirus particles. Similar experiments with blood from 3 seronegative donors from the same families and 4 normal controls proved negative. Our findings indicate that seropositive individuals harbour the virus in a population of T-lymphocytes which may then acquire receptors for IL-2. These individuals are at risk of developing ATLL.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013784     DOI: 10.1002/ijc.2910380108

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features.

Authors:  K Eguchi; N Matsuoka; H Ida; M Nakashima; M Sakai; S Sakito; A Kawakami; K Terada; H Shimada; Y Kawabe
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

Review 2.  The epidemiology of HTLV-I infection.

Authors:  N Mueller
Journal:  Cancer Causes Control       Date:  1991-01       Impact factor: 2.506

3.  A serosurvey for HTLV-I among high-risk populations and normal adults in Egypt.

Authors:  N T Constantine; M Fathi Sheba; A L Corwin; R S Danahy; J D Callahan; D M Watts
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

4.  HTLV-I infection in Britain.

Authors: 
Journal:  BMJ       Date:  1990-09-01

Review 5.  Epidemiology and the prevention of cancer: some recent developments.

Authors:  R Doll
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

6.  Constitutive IL-2 expression in HTLV-I-infected leukaemic T cell lines.

Authors:  J P Farcet; F Lebargy; C Lavignac; P Gaulard; A Dautry; L Gazzolo; P H Roméo; W Vainchenker
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

Review 7.  Adult T-cell leukemia-lymphoma.

Authors:  S M Neely
Journal:  West J Med       Date:  1989-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.